Renewable Design for Fda Approved Portable Ipl - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical
Renewable Design for Fda Approved Portable Ipl - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical Detail:
Our Leukocyte Removal Filters(bedside) is designed to remove the leukocytes and micro-aggregate in blood and protect patients from leukocyte-related transfusion complications such as GVHD diseases and adverse reactions etc.
Residual WBC count less than≤1.0×106/unit
High RBC recovery rate≥90%
100%removal of micro-aggregates
It consists of a pre-filtration, filter, the pipelines, air filter.
1.Pre-filtration will remove micro-aggregate in the blood, and prevent the bubble entering the main filter
2.The filter is the core part where the leukocytes can be filtered and absorbed.
3.The pipelines consist of the saline solution pipeline and the blood pipeline. By irrigating the pipelines with saline solution after filtration, the red blood cells in the pipelines can be recovered thoroughly.
4. Air Filter will prevent the particles into the filter kit.
Certificate:CE, ISO9001, ISO14001, IS013485
Product detail pictures:
Related Product Guide:
Reproducing pediatric kidney disease from human iPS cells | In-Line Filter
Outlander Season 4 Episode 6 Review: Blood of My Blood | In-Line Filter
We are experienced manufacturer. Wining the majority of the crucial certifications of its market for Renewable Design for Fda Approved Portable Ipl - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical, The product will supply to all over the world, such as: Lebanon , Malaysia , Washington , We'll continue to devote ourselves to market & product development and build a well-knit service to our customer to create a more prosperous future. Please contact us today to find out how we can work together.
By Elsa from Dubai - 2016.11.20 15:58
The company has a good reputation in this industry, and finally it tured out that choose them is a good choice.
By Olga from Hamburg - 2015.10.01 14:14